Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
Sociedad Española de Cardiología [Automatic translation follows] The SEC is a non-profit scientific and professional organization dedicated to increasing the state of knowledge about the heart and circulatory system, to advancing the prevention and treatment of its diseases, as well as improving the survival and quality of life of heart patients. The objectives of the Spanish Society of Cardiology are the following: * To lead knowledge about cardiovascular diseases. * To contribute to international research, especially in Europe and Latin America. * To create national and international links for the development of actions and the distribution of resources in cardiovascular matters. * To represent … | 11 | 6 | 3 | 138 | |
Centro de Investigación Príncipe Felipe (CIPF) More research, better health For almost 50 years researchers of this Center have made great efforts to place our Center among those achieving excellence in research. Several breakthroughs have been made in key areas such as Regenerative medicine, cancer, new therapies, neuronal damage. Our goal is to do biomedical research including basic genes, targets, molecular and cellular processes, nanomedicine and Computational Medicine and its translation into clinical practice We have special interest in personalized medicine, cancer, rare diseases, metabolic, and cognitive and functional impairment. In addition to the objective of advancing into biomedical knowledge of impact, at the CIPF we … Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech biotech deeptech | 11 | 4 | 8 | 214 | |
AESEG [Automatic translation follows] We are the employers' association of the generic pharmaceutical industry in Spain. AESEG is the employers' association of the generic pharmaceutical industry in Spain and the qualified business interlocutor in this area. All pharmaceutical specialty laboratories, companies that manufacture raw materials and active pharmaceutical ingredients or technological development companies whose main activity is in the field of generics within the national territory can become members of AESEG. AESEG was established in Barcelona on March 17, 1998 as a national non-profit organization, to promote the knowledge and use of generic drugs, creating a true generic culture within Spanish … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 1 | 4 | 11 | |
ChemoMetec We are a worldwide leading manufacturer in cell counting and analysis. Born in Scandinavia, operating globally. ChemoMetec is a worldwide leading manufacturer of cell counting and analysis equipment. We specialize in developing and producing high-precision instrumentation, delivering consistent data for thousands of customers across biotech, pharma and academic segments. We are experiencing exponential growth, as the company strives towards our goal to be the number one provider in Life Sciences. Designed, manufactured and tested in Denmark, our instruments and consumables are built with quality materials and dedicated expert workmanship. Find us on Glassdoor: https://bit.ly/3pjjzTA Manufacturing Cell Counters, Manufacturing Cell Analyzers, … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 6 | 0 | 1 | 189 | |
Department of Computer Science, University of Copenhagen - DIKU Computing for a better future⭐️ First in Denmark and among the best in Europe🥇 The Department of Computer Science at the University of Copenhagen (DIKU) is the first computer science department in Denmark, established by Turing award winner Peter Naur in 1970. Since then, our researchers and graduates have formed the basis for society’s accelerating technological transformation, and our research environment and results have made us one of Europe’s leading and most attractive computer science departments. Follow us and stay updated on department news, events, and vacant positions. Research, Education, Innovation, Industry collaboration, Computer Science, Algorithms & Programming Languages, High … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech edtech it services | 5 | 0 | 3 | 184 | |
iMotions Powering Human Insight "iMotions is now a Smart Eye company. In October 2021 Smart Eye acquired iMotions. iMotions continues to be independently-run, while the combined companies are working to create the first powerhouse for analyzing emotional, cognitive and behavioral data, delivering holistic human insights." The iMotions software helps unpack human behavior by combining multiple biosensor data to uncover underlying emotions and responses. The platform enables research in market studies, academics, healthcare, UX, automotive, advertisement, education, and more. iMotions is used worldwide by leading universities such as Harvard, Yale, MIT, and Stanford as well as corporations such as gsk, P&G, Unilever, … Type: SMB Activities: biotech deeptech healthtech it services martech regtech uxtech Technologies: Data Analytics | 11 | 0 | 10 | 68 | |
Zealand Pharma Changing lives with next generation peptide therapeutics Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 3 | 2 | 336 | |
Misereor Ally for a just world. Since 1958, we support people in areas where poverty is greatest. We actively fight injustice, violence and poverty with no ifs or buts. Together with our project partners in Africa, the Middle East, in Asia, Oceania, Latin America and the Caribbean as well as with people like you we help people help themselves. We champion a better future and a live of dignity for all. However, Misereor does not just fight poverty, hunger and injustice, but also their causes. As a political lobbying organisation for the disadvantaged, Misereor is critical of the prevailing global economic … Type: SMB Activities: biotech Technologies: Decarbonization | 4 | 1 | 4 | 259 | |
BVMed - Bundesverband Medizintechnologie [Automatic translation follows] BVMed is the voice of the German MedTech industry BVMed is the voice of the German MedTech industry. We represent more than 300 manufacturers, suppliers and dealers in the MedTech industry as well as medical device providers and homecare providers. About the industry: 265,000 employees | 93% SMEs | +40 billion € total turnover | 9% investment in R&D | 68% export Imprint: bvmed.de/impressum Medical devices, medical technology, CE marking, reimbursement, market access, reimbursement, benefit assessment, regulatory issues, and health policy Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 20 | 1 | 20 | 39 | |
BASF Pharma Solutions Inspiring Medicines for better Lives BASF Pharma Solutions produces innovative excipients and active ingredients of outstanding quality and performance. With a global team of industry experts and digital solutions, BASF supports its customers in developing efficient, cost-effective and reliable formulations. Equipped with an in-depth understanding of multiple technologies and applications, we have the knowledge and resources to make pharmaceutical drug delivery and the manufacturing of drugs and biologics safer and more sustainable. We create solutions for Biopharma, Parenteral, Oral, Solubilization and Topical applications and are also a leading supplier of selected APIs such as ibuprofen, L-menthol and Omega-3. About BASF … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 3 | 0 | |
TME Pharma Developing novel therapies for treatment of the most aggressive cancers by acting on the tumor microenvironment (TME) TME Pharma is a clinical-stage company focusing on developing novel therapies for treatment of the most aggressive cancers. We specialize in approaches targeting the tumor microenvironment (TME) in which cancer cells exist. Our unique technology breaks tumor protection barriers against the immune system and blocks tumor repair by neutralizing chemokines in the TME. TME Pharma’s approach works in combination with other forms of treatment to weaken tumor defenses and enable greater therapeutic impact. TME Pharma’s mission is to improve treatment outcomes for patients … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 1 | 2 | 19 | |
GoingPublic Media AG [Automatic translation follows] NEWS: #shares I #stock exchange I #esg I #financial market I #annual general meeting I #ipo I #IR I #capital market I #m&a I #MAB I #spacs I Founded in 1998, GoingPublic Media AG (www.goingpublic.ag) is one of the leading media houses for corporate finance and investment topics. As part of its cross-media platform approach, the group publishes around 35 issues annually and operates 3 web platforms in conjunction with online newsletters and social media presences. In addition, the media house organizes around 15 events per year. GoingPublic Magazine, the capital market portal www.goingpublic.de, HV Magazine and … | 33 | 4 | 32 | 20 | |
SIRION BIOTECH GmbH (Revvity Gene Delivery) Any Gene to Any Cell Viral Vector Services from Vector Engineering and Manufacturing to Cell and Gene Therapy Development Revvity Gene Delivery (formerly SIRION Biotech) supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. Whether you need small scale viral production or full scale viral vector optimization and manufacture, our expert team has you covered. For additional information, please visit www.sirion-biotech.com. AAV, Lentivirus, Custom viral vectors, Virus production, AAV engineering for gene therapy, LentiBOOST, and Gene delivery Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 1 | 0 | 39 | |
Tubulis GmbH Reimagining ADCs. Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Our goal is to expand the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. We will advance a range of conjugates, unlimited by indication, using our own discovery capabilities and by solving development challenges for partners with both antibody and chemical assets. Antibody Drug Conjugates, Targeted Therapy, Biotechnology, and Drug Development Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 2 | 1 | 46 | |
RCSB Protein Data Bank Enabling Breakthroughs in Scientific and Biomedical Research and Education. The Protein Data Bank (PDB) was established in 1971 as the 1st open access digital data resource in all of biology and medicine. It is today a leading global resource for experimental data central to scientific discovery. Through an internet information portal and downloadable data archive, the PDB provides access to 3D structure data for large biological molecules (proteins, DNA, and RNA). These are the molecules of life, found in all organisms on the planet. Knowing the 3D structure of a biological macromolecule is essential for understanding its role in human … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech edtech energytech | 4 | 0 | 2 | 26 | |
uniQure Transforming the lives of patients through gene therapy uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases. aav and lpl Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 2 | 2 | 0 | 430 | |
Fraunhofer Institute for Interfacial Engineering and Biotechnology We combine biology and engineering The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB develops and optimizes processes, technologies, and products for health, sustainable chemistry and the environment. In doing so, we rely on the unique combination of expertise in biology and the engineering sciences in order to contribute to human welfare, a sustainable economy, and an intact environment with the systems approach of bioeconomy as well as bioinspired, biointegrated and biointelligent solutions. Working closely with partners from universities and industry, the IGB covers the entire innovation chain from fundamental research to industrial implementation. We provide our customers with research … Type: SMB Activities: deeptech biotech Technologies: New Materials Synthetic Biology | 13 | 5 | 2 | 228 | |
Bicoll We envision molecules for epilepsy and longevity: Research and development of novel patentable structures. Bicoll is an expert in bioactive plant-derived small molecules with outstanding expertise in high-tech natural product chemistry and validated experience in medicinal chemistry. Currently Bicoll focuses on two main fields such as neurodegenerative disorders (primarily, epilepsy) and longevity. In both of the fields it develops own preclinical candidates. Drug Discovery Services, Custom Synthesis, Medicinal Chemistry Services, Natural Product, Plant-based compounds, Food supplements, Nutraceuticals, and Cosmetics Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 0 | 0 | 14 | |
CureVac We fight for human health - we are the RNA people CureVac (Nasdaq: CVAC) is a pioneering multinational biotech company founded in 2000 to advance the field of messenger RNA (mRNA) technology for application in human medicine. In more than two decades of developing, optimizing, and manufacturing this versatile biological molecule for medical purposes, CureVac has introduced and refined key underlying technologies that were essential to the production of mRNA vaccines against COVID-19, and is currently laying the groundwork for application of mRNA in new therapeutic areas of major unmet need. CureVac is leveraging mRNA technology, combined with advanced omics … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 13 | 3 | 8 | 876 | |
VITA34 AG [Automatic translation follows] We enable a more vital future for everyone. VITA 34 - THE FUTURE LIES IN LEIPZIG With the largest cell bank in the German-speaking region, Vita 34 is the expert in storing stem cells obtained from the umbilical cord at birth. Stem cells are already the basis of numerous medical applications. With personalized therapies tailored to individual needs, they will help shape the medicine of tomorrow. Since 1997, Vita 34 has been helping to make this vision a reality. As a full-service provider with around 100 employees, we provide services from collection to processing and preservation to … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 47 | |
Balluff EMEA We are your partner for innovative solutions in industrial automation. With our passion we improve your competitive position with speed and results. 🏁 🏆 With our 100 years company history and more than 60 years of sensor experience, Balluff is a world leader and one of the most efficient manufacturers of sensor technology. Balluff is a leading supplier of high-quality sensor, identification and image processing solutions including network technology and software for all automation requirements. We stand for: ✨ Proven technology ✨ Continuous innovation ✨ Experienced application support ✨ Highest quality ✨ Greatest reliability ✨ Maximum customer orientation Blog: https://www.innovating-automation.blog/ … Type: Large company Activities: biotech deeptech healthtech industry 4.0 nanotech | 14 | 3 | 6 | 1,827 | |
Oxford Biomedica A quality and innovation-led CDMO in cell and gene therapy OXB (LSE: OXB) is a quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies. The Company collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 19 | 4 | 9 | 759 | |
MagForce NT GmbH Pioneers in nanotechnology-based cancer treatment MagForce is forging new paths to treat cancer successfully and gently. With NanoTherm® Therapy System (NTTS), we have developed an innovative approach based on nanotechnology, which we want to make available to patients worldwide. And we are getting closer and closer to this goal. NTTS is the first and only nanotechnology-based therapy with European approval for treating recurrent Glioblastoma, a deadly brain tumor. To date, many patients diagnosed with Glioblastoma tumors have improved their quality of life after using our technology. Nanomedicine, Oncology, Brain Tumor, Nanotechnology, Glioblastoma, Prostate Cancer, Medical Devices, Medical Technology, and Thermotherapy Type: SMB Activities: healthtech deeptech nanotech biotech Technologies: Synthetic Biology | 1 | 1 | 1 | 41 | |
Shimadzu Europa GmbH The most extensive product range for instrumental analysis, life sciences, physical testing, imaging and medical systems Future-oriented high quality solutions - best for your individual needs Shimadzu provides a broad range of analytical instruments indispensable for research, development, and quality control in a variety of fields. Our high-level, sophisticated instruments include chromatographs, spectrometers, and elemental and surface analysis systems. We also provide a broad range of high-precision physical testing and measuring technology that is essential for product development and quality assurance. Our high - class systems cover - Gas Chromatography - Liquid Chromatography - Mass Spectrometry - Consumables - Spectroscopy … Type: SMB Activities: biotech deeptech manufacturing Technologies: New Materials | 3 | 0 | 3 | 132 | |
PromoCell Leading biotechnology company who supports scientists worldwide with high-end human cell culture products and services. At PromoCell, we help scientists do better research with a world-class portfolio of human primary, stem and blood cells as well as optimized cell culture media. With over 30 years of expertise, we are recognized globally for supplying scientists with the tools and support they need to do groundbreaking research. All our products comply with European biomedical conventions, ensuring human rights and donor privacy are always protected. Our ISO certifications demonstrate our absolute commitment to quality and our EXCiPACTTM GMP certification enables us to produce … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 0 | 2 | 83 | |
SFL is now Veristat Solutions For Life sciences SFL, a Veristat company - Integrated Solutions for Healthcare Products SFL is a leading consultancy providing integrated solutions to pharma, biotech and medtech companies for all product life cycle stages: Regulatory Affairs & Regulatory Intelligence, Quality & Supply Chain, Medical Writing, Public Affairs & Market Access, Pharmacovigilance, and Healthcare Compliance. In addition, SFL can act as marketing authorization applicant and MAH in Switzerland and the EU and conduct submissions to FDA, PMDA and Health Canada and other authorities. As a Veristat company, SFL clients also have access to a substantial range of clinical development services such … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 0 | 10 | 426 | |
European Academy of Allergy and Clinical Immunology - EAACI Dedicated to science - Committed to your health The European Academy of Allergy and Clinical Immunology (EAACI) is a non-profit organization active in the field of allergic and immunologic diseases such as asthma, rhinitis, eczema, occupational allergy, food and drug allergy and anaphylaxis. EAACI was founded in 1956 in Florence and has become the largest medical association in Europe in the field of allergy and clinical immunology. It includes over 12,000 members from 124 countries, as well as 74 National Allergy Societies. EAACI’s mission is to promote basic and clinical research; to collect, assess and diffuse scientific information; to act … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 2 | 2 | 152 | |
MedXCell SA The Cell Therapy Venture Builder MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities. Biotechnology, Cell Therapy, Immunotherapy, NK Cells, Mesenchymal Stromal Cells, Immuno-oncology, and Osteoarthritis Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 8 | |
BIOTECH AUSTRIA With innovation to World class BIOTECH AUSTRIA is the association of the Austrian biotechnology industry and has set itself the goal of supporting the development of an innovative branch of industry based on modern life sciences. Biopharma, Unternehmertum, Healthcare, Biotechnologie, Life Science, Biotechnology, Biotech, and Entrepreneurship Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech | 5 | 1 | 0 | 5 | |
AC Immune We shape the future of neurodegeneration by discovering and developing breakthrough therapies through pioneering science AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigenTM and MorphomerTM, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical … Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 4 | 1 | 2 | 170 | |
BC Platforms From Data to Health BC Platforms is a global leader in Real-World Data, Technology Platforms and Services. We build data networks for life science and provide versatile technology platforms for personalised medicine, accelerating the translation of innovations into clinical practice. We convert complex biological information collected in the healthcare setting into actionable insights. With our innovative technology we are creating a patient centric infinity loop between the life sciences and healthcare sectors. Data we generate, harmonise, and manage, from diverse biobanks and healthcare institutions, is made accessible for pharmaceutical and biotech companies to enhance their core strengths in research and … Type: SMB Activities: healthtech deeptech biotech it services Technologies: Data Analytics | 9 | 1 | 9 | 166 | |
BIOTECanada Solving for today. Building for tomorrow. BIOTECanada is the national industry association voice. With over 230 member companies, the Association’s membership is representative of the broader Canadian biotech ecosystem which is national in scope and comprised of pre-commercial biotech companies, global pharma and biotech companies, investors, incubator and accelerator organizations, and academia. In the context of global population growth and corresponding climate change, food sustainability, and human health needs, the biotechnology industry plays a vital role in developing solutions to help address the resulting human health and environmental challenges. Type: SMB Activities: deeptech biotech Technologies: Decarbonization | 26 | 3 | 21 | 26 | |
Canadian Dermatology Association The Canadian Dermatology Association, founded in 1925, represents Canadian certified dermatologists. Founded in 1926, the Canadian Dermatology Association represents Canadian certified dermatologists. The association exists to advance the science and art of medicine and surgery related to the health of the skin; provide continuing medical education for its members; support and advance patient care; offer public education on sun protection and other aspects of skin health; and promote a lifetime of healthy skin, hair and nails. Dermatology Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech biotech deeptech | 5 | 2 | 5 | 25 | |
The Leukemia & Lymphoma Society of Canada Supporting the blood cancer community. You are not alone; we are here to help! BloodCancers.Ca The Leukemia & Lymphoma Society of Canada (LLSC) is a voluntary health agency dedicated to blood cancer. LLSC funds lifesaving blood cancer research across Canada and worldwide, and provides free information and support services. We won’t stop until there is a cure for leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative neoplasms and are able to improve the quality of life of people affected by blood cancers and their families by funding life-enhancing research and providing educational resources, services and support. Our strategy to achieve the … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech | 6 | 2 | 5 | 71 | |
BioNB The voice of the bioscience sector in New Brunswick, BioNB advocates for the sector and works to raise its profile. Driving New Brunswick’s bioeconomy: BioNB connects, supports, and advocates for NB’s biosciences sector. BioNB offers a range of business services from proposal editing to collateral design and business plan development to pitch coaching. BioNB hosts regular events to foster sector networking and educate companies, decision makers and the public on current issues and emerging trends. In collaboration with a vibrant ecosystem of companies, research institutions and partners, BioNB is dedicated to enabling a thriving bioeconomy in our region. Business development, … | 7 | 0 | 6 | 3 | |
LuminUltra Technologies Ltd. Your partners in microbial management. Because little things make a big difference. We are a global leader in applied molecular biology diagnostics, with solutions and services that deliver accurate and actionable feedback in bioprocessing, biofouling, and biosecurity applications. Founded in 1995 and with operations in six countries, LuminUltra serves dozens of Fortune 500 customers across more than 100 countries. In recent years it has been on an accelerated growth path, acquiring multiple companies after forming a partnership with XPV Water Partners. Biotechnology, Laboratory Equipment, Molecular Diagnostics, RT-qPCR, Reagent, Automated ATP testing, Environmental Monitoring, Microbiological Control, Biofouling, Bioprocessing, Biosecurity, Industrial Monitoring, … | 3 | 0 | 2 | 89 | |
Institute for Research in Immunology and Cancer of the Université de Montréal A global standard bearer in basic and applied research to vanquish cancer IRIC, located in the heart of the Université de Montréal campus, operates according to a unique model in Canada that combines, under one roof, fundamental research activities, a university-level training program and a research maturation team. These generate discoveries that advance knowledge or that can quickly translate into new therapeutic solutions. A unique model that combines, under one roof, fundamental research activities, a university-level training program and a research maturation team. The complementary expertise of 29 Investigators in fundamental, translational and applied research. Innovative teaching methods to train … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 13 | 3 | 12 | 236 | |
BioNeutra North America, Inc. Made by nature, nurtured by Science. BioNeutra North America (TSX: BGA.V) is a supplier of high quality prebiotic, dietary-fiber and low-caloric sweetener products, including VitaFiberTMIMO (www.VitaFiberIMO.com). Founded in 2003, BioNeutra is seeking to become the premier North American supplier of high quality prebiotic and fiber ingredients and products. We are dedicated to addressing the needs of our customers and consumers in both mainstream and functional food markets. Our product line provides ingredients for various food systems, contributing to advanced human nutrition and wellness in functional and healthy foods. Our goal is to move science-based processes into the commercial product marketplace. … | 2 | 1 | 1 | 27 | |
Canadian Securities Exchange (CSE) Always invested. The Canadian Securities Exchange is a rapidly growing stock exchange invested in working with entrepreneurs, innovators and disruptors to access public capital markets in Canada. The Exchange's efficient operating model, advanced technology and competitive fee structure helps its listed issuers of all sectors and sizes minimize their cost of capital and focus on creating a global liquidity profile. Our client-centric approach and corresponding products and services ensure businesses have the support they need to confidently realize their vision. The CSE offers the global investor and trading community access to an innovative collection of growing and mature companies. For … Type: SMB Activities: biotech deeptech fintech Technologies: Cybersecurity | 3 | 0 | 1 | 74 | |
Diagnos Medical Systems (TSX: ADK.V) Deep learning-powered technology capable of diagnosing a wide range of retinal conditions. Welcome and thank you for visiting us on LinkedIn! Diagnos is a publicly-trading Artificial Intelligence company focused on revolutionizing healthcare by developing cloud-based clinical decision support systems designed to enable eye health professionals in making more informed decisions about patient care. One of the key benefits from our Pathology Detection Solutions is that they offer the ability to analyze scans from retinal examinations in a matter of seconds, right at the point of care, thus allowing healthcare professionals to determine the best course of action promptly, leading to … Type: SMB Activities: healthtech biotech Technologies: A.I. A.I. - Deep Learning | 2 | 2 | 0 | 30 | |
Life Sciences BC “Inspiring Minds Advancing Science” Life Sciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry. Biopharmaceuticals, Medical Devices, Medical Technologies, and Digital Health Care Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology | 32 | 5 | 25 | 31 | |
Génome Québec La génomique au service du citoyen, de l'industrie et de la société. Making genomics work for Citizens/Industry/Society. Génome Québec a pour mission de catalyser le développement et l’excellence de la recherche en génomique, son intégration et sa démocratisation. Pilier de la bioéconomie du Québec, l’organisme contribue également au développement social et durable, ainsi qu’au rayonnement du Québec. Génome Québec contribue ainsi à accélérer la découverte de nouvelles applications dans des secteurs stratégiques tels la santé, la foresterie, l’environnement et l'agroalimentaire. Les fonds investis par Génome Québec proviennent du ministère de l'Économie, de l'Innovation et de l'Énergie (MEIE), du gouvernement du … Type: SMB Activities: cleantech agritech biotech deeptech edtech greentech healthtech Technologies: Decarbonization | 20 | 2 | 11 | 73 | |
Radient Technologies Inc. Cannabis Products, Perfected. Radient Technologies Inc. is an expert in the extraction, purification and isolation of high-value naturally derived compounds and ingredients for use in the manufacture of pharmaceutical intermediate, nutraceutical, food and cosmetic products. Radient produces these high-value natural substances by uniquely combining MAP (Microwave Assisted Processing), a patented extraction technology and our proprietary knowledge and experience in the critical downstream processing areas of purification and extraction. High Efficiency extraction of selected compounds from Bio materials using Microwave technology. Type: SMB Activities: biotech deeptech Technologies: Bio sourced materials | 1 | 1 | 1 | 46 | |
The Scientist The Scientist, the magazine of the life sciences, and the 2008 and 2009 ASBPE Magazine of the Year, has informed global life science professionals for over 25 years. We provide our print and online magazine readers with coverage of the latest developments in the life sciences including trends in research, new technology, news, business and careers. We reach the leading researchers and executive management in academia and industry who are interested in maintaining a broad view of the life sciences by reading insightful content that is current, concise and entertaining. For more information about The Scientist, visit http://www.the-scientist.com. Life sciences, … | 2 | 0 | 2 | 45 | |
Bermuda Business Development Agency (BDA) The BDA encourages direct investment and helps companies start up, expand or relocate operations in Bermuda. The Bermuda Business Development Agency (BDA) encourages direct investment and helps companies start up, expand or relocate operations in Bermuda. A public-private partnership, we connect investors and businesses to regulatory officials and key contacts in the Bermuda government to facilitate domicile decisions. Our industry focus groups cultivate innovation, explore new regions, and generate strategic initiatives. To learn more or connect with a BDA representative, go to our website, www.bda.bm. Risk Management, Trust & Private Client, Asset Management, Technology, Life Sciences, Shipping & Aviation Registries, … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech legaltech | 21 | 0 | 16 | 19 | |
Biobest Biobest, we invented the buzziness As a pioneer in the production of bumblebees since 1987, Biobest has become one of the world’s leading companies in natural pollination and biological control of pests and diseases. Known since many years for its bumblebees and wide range of beneficial insects, mites and nematodes, the company now offers a complete range of natural solutions including biopesticides, monitoring and scouting tools, pheromones .... With 28 group companies in 6 continents, distributors in more than 65 countries and over 2.000 employees worldwide, we stand prepared to provide growers with tailor-made advice. We focus on vegetables, ornamentals, … Type: SMB Activities: biotech deeptech Technologies: Bio sourced materials | 6 | 2 | 2 | 354 | |
EORTC - European Organisation for Research and Treatment of Cancer The Future of Cancer Therapy The European Organisation for Research and Treatment of Cancer (EORTC) is a non-governmental, non-profit organisation, which unites clinical cancer research experts, throughout Europe, to define better treatments for cancer patients to prolong survival and improve quality of life. Spanning from translational to large, prospective, multi-centre, phase III clinical trials that evaluate new therapies and treatment strategies as well as patient quality of life, its activities are coordinated from EORTC Headquarters, a unique international clinical research infrastructure, based in Brussels, Belgium. For further information, please visit the EORTC website: www.eortc.org | 16 | 4 | 12 | 338 | |
DNAVision DNAVision is the leading European DNA analysis company providing a complete solution for sequencing projects for research and regulatory purposes. DNAVision is the only service provider to have all the latest technologies for genomic analyses, including Illumina Hiseq2000 and GA2x, Roche 454, ABI genetic analysers, real time PCR equipments, Affymetrix, Illumina microarrays, Agilent, DNA extraction robots... DNAVision provides services in a high quality environment, allowing us to meet customer demands. It is the only laboratory in the world providing these kinds of analyses under ISO 17025, CLIA and CAP accreditation, and GLP and GMP certification! Next generation sequencing, DNA sequencing, … Type: SMB Activities: biotech deeptech Technologies: Robotics | 2 | 2 | 0 | 13 | |
EFPIA - European Federation of Pharmaceutical Industries and Associations Illness never sleeps, so neither can we #WeWontRest The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 41 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world. Twitter : @EFPIA Website : www.efpia.eu Pharmaceutical Industry Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 44 | 21 | 34 | 140 | |
Center for Genomic Interpretation Encouraging careful stewardship of clinical genetics, genomics and precision medicine. The Center for Genomic Interpretation (CGI) is an independent non-profit organization with the mission to save and improve lives through encouraging careful stewardship of clinical genetics, genomics, and precision medicine. Clinical Genetics, Human Genetics, Genetics, Variant Classification, Variant Interpretation, Mutation Analysis, Mutation Interpretation, Mutation Classification, Mutation, Service, Diagnostics, Precision Medicine, Genomics, Clinical Genomics, Consumer Genetics, Fraud, Waste, Abuse, and Health Insurance Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 4 | 0 | 4 | 6 | |
New England Biolabs be INSPIRED, drive DISCOVERY, stay GENUINE Established in the mid 1970's, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including the development of molecular diagnostics, as well as nucleic acid vaccines. … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 16 | 5 | 9 | 755 | |
The Jackson Laboratory Cancer. Diabetes. Alzheimer’s. Heart disease. JAX leads the search to cure diseases rooted in our DNA. OVERVIEW • The Jackson Laboratory is an independent, 501(c)3 nonprofit biomedical research institution founded in 1929 in Bar Harbor, Maine. • Our mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health. • We are a global team of nearly 3,000 people at 11 locations in Maine, Connecticut, California, Japan and China, and in remote locations around the world. • With a 2023 operating budget of $628M, JAX has substantial impact … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 2 | 2 | 2,197 | |
Keratify Advancing skin testing Advancing preclinical human skin testing | 1 | 0 | 1 | 5 | |
ZHAW Institut für Risk & Insurance [Automatic translation follows] Transformation through education - from knowledge to change 🔢 Our activities? • Lessons for over 200 students annually in the various programs • 9 modules in the Risk & Insurance Bachelor of Business Administration specialization • 1 Master of Advanced Studies, 7 Certificates of Advanced Studies • 8 modules in preparation for occupational pension expert (EBV) • Over 2500 teaching hours per year in mathematics • Various research projects, publications, studies, specialist articles on current issues • Events, webinars or day courses on current topics 👩🏫 Our team? • 19 employees • >100 years of professional experience … Type: NGO, Think-tanks, Ed, & Culture Activities: edtech biotech healthtech Technologies: Data Analytics A.I. - Machine Learning | 48 | 12 | 35 | 5 | |
SusChem Let’s drive sustainable chemistry together! SusChem is the European Technology Platform for Sustainable Chemistry. It was created in 2004 as a joint initiative between Cefic, DECHEMA, EuropaBio, GDCh, ESAB and RSC with the main objective to revitalise and inspire European chemistry and industrial biotechnology research, development and innovation in a sustainable way. Visit www.suschem.org if you want to learn more about SusChem. Type: NGO, Think-tanks, Ed, & Culture Activities: cleantech biotech deeptech greentech | 12 | 2 | 9 | 13 | |
CÚRAM, SFI Research Centre for Medical Devices A Science Foundation Ireland centre designing the next generation of ‘smart’ implantable medical devices CÚRAM is a multidisciplinary research centre advancing R&D in the medical device sector. Supported by Science Foundation Ireland and industry partners, CÚRAM enhances Ireland’s standing as a major hub for the global medical devices industry. CÚRAM focuses on an academic-industry-clinician led strategy that facilitates innovative, technical and transformative solutions to be developed for the current and emerging medical devices industry. The centre proactively seeks out and collaborates with industry partners. Support for industry ranges from basic scientific research, translation through preclinical and clinical development into regulatory … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech | 7 | 0 | 5 | 63 | |
Borderless Executive Search Executive Search for the global chemical value chain, industrial solutions, food & drink and life science sectors Clients in life sciences, across the chemicals value chain and food processing sectors retain Borderless to search globally for executive talent. Borderless has developed an extensive global network, enabling us to identify and source talented international executives for these sectors, no matter where they are located. 1,200. That’s how many executives placed by Borderless now contribute to the success of our clients. And while we are proud of the positions these executives have attained in their industries, we must also ask ourselves, what … Type: SMB Activities: deeptech healthtech biotech civictech fintech hrtech | 1 | 1 | 0 | 18 | |
AARDEX Group - Medication Adherence Tools Prescribing the Future of Medication Adherence Management 💊 At AARDEX Group, we believe in the power of digital solutions to revolutionize the way we measure and manage medication adherence. We're not just talking the talk; we're walking the walk as the world leader in this space. Our cutting-edge technology, MEMS® Adherence Software (MEMS AS®), is the cornerstone of a comprehensive ecosystem designed to deliver accurate, data-driven adherence analytics across all forms of drug administration. But we don't stop there. Our team is dedicated to continuously innovating and pushing the boundaries of what's possible in the world of clinical trials. Our … Type: SMB Activities: healthtech biotech deeptech Technologies: Data Analytics | 4 | 2 | 2 | 28 | |
Medicines for Europe Medicines for Europe represents the generic, biosimilar and value-added medicines industries across Europe. Its vision is to provide sustainable access to high quality medicines, based on 5 important pillars: patients, quality, value, sustainability and partnership. Its members directly employ 190,000 people at over 400 manufacturing and 126 R&D sites in Europe and invest up to 17% of their turnover in R&D investment. Medicines for Europe member companies across Europe are both increasing access to medicines and driving improved health outcomes. They play a key role in creating sustainable European healthcare systems by continuing to provide high quality, effective generic medicines, … Type: SMB Activities: biotech deeptech Technologies: Decarbonization | 11 | 4 | 9 | 53 | |
Centre for Genomic Regulation (CRG) We are an international biomedical research lab based in Barcelona, a CERCA centre at the forefront of life sciences. The Centre for Genomic Regulation (CRG) is an international biomedical research institute of excellence, created in December 2000. It is a non-profit foundation funded by the Catalan Government through the departments of Economy & Knowledge and Health, the Spanish Ministry of Economy and Competitiveness, "la Caixa" Banking Foundation, and includes the participation of Pompeu Fabra University (UPF). The mission of the CRG is to discover and advance knowledge for the benefit of society, public health and economic prosperity. The CRG believes … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 10 | 3 | 2 | 456 | |
FreshBlood HealthTech We support healthcare innovation in Romania and Eastern Europe. FreshBlood is an Non Governmental Organization aiming to support health innovation by connecting innovators to things that they need, providing feedback and mentoring. FreshBlood helps new startups in healthcare by merging medical knowledge with technology. We are exploring the potential to solve challenges that healthcare faces nowadays. Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech | 3 | 2 | 1 | 7 | |
QIMR Berghofer Medical Research Institute Translational research in #cancer, #infectious diseases, #mental health and #chronic disorders QIMR Berghofer is a world-leading translational research institute. Our research focuses on cancer, infectious diseases, mental health and a range of chronic disorders. Working in close collaboration with clinicians and other research institutes, our aim is to improve health by developing new diagnostics, better treatments and prevention strategies. All the latest news, events and research updates are posted on our website or you can get involved by engaging in our conversations on Facebook, Twitter, YouTube, Instagram and LinkedIn. For more information, visit www.qimrberghofer.edu.au Medical research, Translational research, Clinical trials, … Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech biotech deeptech | 5 | 1 | 5 | 693 | |
Syntara Syntara is an Australian pharmaceutical research company developing drugs for inflammatory and fibrotic diseases Syntara Limited (ASX:SNT) is a clinical stage drug development company targeting extracellular matrix dysfunction with its world-leading expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. Syntara is managing three phase 2 clinical studies in diseases of high unmet need with a further two potential phase 1c/2 studies being evaluated for 2024. Lead candidate SNT‐5505 is for the bone marrow cancer myelofibrosis which causes a build-up of scar tissue that leads to loss … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 1 | 57 | |
Leukaemia Foundation The Leukaemia Foundation stands with Australia to help cure and conquer every blood cancer – with care. The Leukaemia Foundation is the only national charity dedicated to helping those with leukaemia, lymphoma, myeloma and related blood disorders survive and then live a better quality of life. It exists only because of the generous and ongoing support of the Australian community. Leukaemia, lymphoma and myeloma are all types of blood cancer and they can develop in anyone, of any age, at any time. Another 53 Australians are diagnosed each and every day. Although improved treatments and care are helping more people … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech | 5 | 4 | 2 | 224 | |
OpGen, Inc. Mission We harness the power of molecular microbiology to develop diagnostic solutions that will optimize the treatment of life-threatening, drug resistant infections. We seek to dramatically transform patient care to guide antibiotic therapy selection and help improve antibiotic stewardship. About Headquartered in Rockville, Maryland, OpGen (NASDAQ:OPGN) is a precision medicine company harnessing the power of molecular diagnostics to help combat infectious disease. Our innovative approaches to infectious disease diagnostics consist of highly multiplexed syndromic molecular panels to address the global threat of antimicrobial resistance (AMR), improve antibiotic stewardship, and decrease the spread of multidrug-resistant microorganisms (MDROs). Together we improve patient … Type: SMB Activities: biotech deeptech Technologies: A.I. Synthetic Biology | 6 | 0 | 2 | 48 | |
BioMelbourne Network Victorian industry association providing a focal point for connectivity and leadership across the Health Industry BioMelbourne Network’s mission is to foster the development of an advanced, innovation driven and sustainable health industry. As a for-purpose, industry led membership association, we encompass biotechnology, medical technology, pharmaceuticals and health innovation companies in the state of Victoria. We connect business, research, finance, health and government to support and promote the sector’s growth and facilitate the development and commercialisation of new drugs, devices, diagnostics and digital health technologies in Victoria. Since 2001, we have championed an environment that enables Victorian organisations to innovate, commercialise … Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 18 | 2 | 18 | 20 | |
ASPHALION Scientific and Regulatory Affairs consultancy with offices in Barcelona, Madrid, Pamplona, Munich and London. Asphalion is an international Scientific, Regulatory and Safety Consulting In Life Sciences, with offices in Barcelona, Madrid, Pamplona, Munich and London. We collaborate with Pharma and Biotech companies facilitating Drug Development and Regulatory Affairs projects for Drugs, Biologics, Biosimilars, ATMPs and Medical Devices. Our involvement ranges from early development, throughout registration, until marketing and post-commercialization phases. Since the company foundation in 2000, we have consistently grown and now have a team of over 100 employees with backgrounds in all areas of life sciences. Our consultants are … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 9 | 0 | 9 | 11 | |
Breast Cancer Trials Trials Save Lives Breast Cancer Trials is a group of world-leading breast cancer doctors and researchers based in Australia and New Zealand with a commitment to exploring and finding better treatments for people affected by breast cancer through clinical trials research. Formerly known as the Australia & New Zealand Breast Cancer Trials Group and our fundraising department, the Breast Cancer Institute of Australia, we are on a mission for people affected by breast cancer to live better, to live longer and to never die from breast cancer. And we support all leading breast cancer researchers and organisations around the world … | 10 | 1 | 9 | 67 | |
Life Science Nord The network for the industrial healthcare sector in Northern Germany Life Science Nord is one of the leading industry networks in Europe. Around 500 companies, research institutions and institutions from the medtech, biotech and pharmaceutical industries shape the cluster of the two northern German states of Hamburg and Schleswig-Holstein. Medtech, Medical Technology, Medizintechnik, Biotech, Biotechnologie, Pharma, Life Sciences, Digital Health, Diagnostics, Startup, Cluster, Health, Innovation, Networking, medical device, and pharmaceutical Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech | 15 | 0 | 14 | 20 | |
Kazia Therapeutics Limited Kazia Therapeutics (NASDAQ: KZIA) is developing innovative treatments for cancers with significant unmet need. Kazia Therapeutics Limited (NASDAQ: KZIA) is an oncology-focused drug development company. Our lead program is paxalisib, which is being developed to treat glioblastoma (GBM), the most common and aggressive form of primary brain cancer in adults. There are few treatment options for sufferers of GBM and around 65% of sufferers do not respond to currently available treatments. The condition affects around 133,000 people globally per annum and the potential addressable market is worth more than US$1 billion. Kazia’s drug paxalisib, commenced recruitment to GBM AGILE, a … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 14 | |
Gyros Protein Technologies Leading provider of peptide synthesis and bioanalytical tools for biotherapeutics, cell & gene therapies, and vaccines Gyros Protein Technologies provides enabling peptide synthesis and immunoassay bioanalytical tools that help scientists increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications. With a large and growing installed base of instruments for nanoliter scale immunoassay automation (Gyrolab® xPand and Gyrolab xPloreTM), and peptide synthesis (PurePep® Chorus, Symphony® X and PurePep® Sonata®+) in the biopharmaceutical industry and related markets, the solutions from Gyros Protein Technologies accelerate discovery, development, and manufacturing of safer and more efficacious biotherapeutics, cell … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 0 | 4 | 137 | |
WEHI (Walter and Eliza Hall Institute of Medical Research) Brighter together WEHI (formerly the Walter and Eliza Hall Institute of Medical Research) brings the world’s brightest minds together to make life-changing discoveries. With more than 1000 researchers from across the globe, we are making discoveries for cancer, infectious and immune diseases, developmental disorders and healthy ageing. Our researchers are committed to long-term discovery, collaborating with partners in science, health, government, industry and philanthropy. Cancer, Inflammatory disorders, Immune disorders, Infectious diseases, medical research, and Healthy ageing Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 10 | 6 | 7 | 1,060 | |
Aridis Pharmaceuticals Leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections Aridis Pharmaceuticals is a late-stage clinical development company leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections. The company’s pipeline of novel mechanism antibacterial and antivirals, sprung from its proprietary technology platforms, are designed to combat the growing public health threat of antimicrobial resistant bacteria (AMR). Monoclonal Antibody , Infectious Disease, Cell line Engineering, Inhalation therapy Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 24 | |
GeNeuro SA We focus on Human Endogenous Retroviruses (#HERVs) to fight neurodegeneration in #MS, #ALS and #LongCovid $GNRO GeNeuro is a biotechnology company developing innovative treatments against inflammatory and neurodegenerative disorders associated with Human Endogenous Retroviruses (HERVs). We are committed to fight the progression of disability in Multiple Sclerosis #FightMS and other neurodegenerative diseases #ALS #LongCOVID Our Community Guidelines: http://bit.ly/36y9YCE Multiple Sclerosis, Progressive MS, ALS, SLA, HERV, and Autoimmune diseases Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 1 | 1 | 0 | 21 | |
KOBE Biomedical Innovation Cluster Kobe - Gateway to Japan's Largest Biocluster Innovation Community KOBE Biomedical Innovation Cluster (KBIC) is the largest biomedical cluster in Japan, and it offers a platform of networking for businesses and institutes in their pursuit of innovative collaboration. KBIC currently boasts a concentrated network of close to about 370 companies, universities, research institutes, and specialized hospitals, in addition to a growing network of international bio-cluster partners, who are all focused on the development of innovative medical technology and pioneering discoveries through collaboration. KBIC is also the home of the Foundation for Biomedical Research and Innovation at Kobe (FBRI), which vigorously … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech | 1 | 1 | 1 | 16 | |
ChemCentre Chemistry for the benefit of every Western Australian ChemCentre is the Western Australian Government statutory authority that provides expert analytical and scientific information to government, industry and the community. It exists to provide essential chemical and forensic services to ensure a safe and prosperous Western Australian community. ChemCentre was established by the Western Australian Government in the 1890s and has grown and evolved over the past 120 years to achieve recognition as a leader in analytical chemistry and forensic science. We provide routine analytical services, as well as specialised method development and unique analyses for less common chemicals of interest. … | 1 | 0 | 0 | 192 | |
Starpharma Starpharma is a global biopharmaceutical company and a world leader in the development of dendrimers. Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for respiratory viruses, DEP® drug delivery and VivaGel®. Medical Devices, Pharmaceuticals, and Dendrimer Drug Delivery Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology | 3 | 0 | 4 | 73 | |
LISAvienna Connecting Life Sciences LISAvienna is the cluster platform for life sciences in Vienna, which was set up at the interface of Austria Wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry of Labour and Economy and the City of Vienna, it contributes to the further development of the industry. LISAvienna supports innovative companies in the fields of biotechnology, pharmaceuticals, medical products and digital health that develop new products, services and processes in Vienna and bring them to market internationally. The platform connects these companies with development partners and lead customers. As a thought leader, LISAvienna provides … Type: SMB Activities: deeptech biotech healthtech Technologies: SaaS | 18 | 2 | 15 | 7 | |
Research Institute of Molecular Pathology (IMP) A leading basic research institute addressing fundamental questions in molecular biology. Part of Vienna BioCenter. The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 40 countries, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, microscopy, immunology and cancer, developmental biology, chromosome biology, and computational biology. Molecular Biology, Disease Mechanisms, Computational biology, Immunology, Cell Biology, Chromosome Biology, Gene Regulation, Developmental Biology, and Microscopy Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 | 2 | 204 | |
Vienna BioCenter Vienna BioCenter is a leading life sciences campus in Europe, and we are hiring! Vienna BioCenter is a leading life sciences location in Europe, offering a unique combination of research, education and companies on a single campus: 2,800 employees, 1,500 students, 145 research groups, and 39 biotech companies. Over the last thirty years, the Vienna BioCenter has developed into one of the leading multi-disciplinary biomedical research centers in Europe and into the premier location for Life Sciences in Austria. Its institutions and companies are among the European leaders in their field and have been able to attract excellent scientists as … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 7 | 5 | 3 | 46 | |
Centre for Cellular and Molecular Platforms (C-CAMP) Fostering deep science research and innovation for societal impact Centre for Cellular And Molecular Platforms (C-CAMP) is an initiative of Dept of Biotechnology, Ministry of Science and Technology, Govt. of India, with a mandate to be an enabler of cutting edge Life Science Research and Innovation. C-CAMP is also a member of the Bangalore Life Sciences Cluster (BLiSC). We facilitate Bioscience Research and Entrepreneurship by providing Research, Development, Training and Services in state-of-the-art Technology Platforms. As a part C-CAMP's mandate of promoting entrepreneurship and innovation, C-CAMP has created and fostered an entrepreneur-friendly culture in and around Academic/Research environment through its … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 36 | 2 | 33 | 137 | |
Scientechnic Embracing new technologies to enable and enrich the community in a sustainable manner. Right from the sparkling first glimpse of this dynamic country to the good times you enjoy at the landmarks of Dubai; from the switch boards at your home to the lighting on your streets or the vibrance at the Sharjah Cricket Stadium and the breath taking Atlantis Hotel to the iconic Burj Khalifa or the awe inspiring Grand Mosque in Abu Dhabi to the energetic Yas Marina Circuit- we have been touching lives since 1972, every single day... Industrial Stock Sales, Automation Products, Building Technologies, Power Projects … Type: SMB Activities: biotech deeptech healthtech industry 4.0 transporttech Technologies: Decarbonization | 4 | 0 | 4 | 648 | |
Eastern Biotech & Life Sciences PREDICTIVE.PREVENTIVE.PERSONALIZED HEALTHCARE Eastern Biotech & Life Sciences based at DuBiotech, Dubai, is the first company in the Middle East to offer comprehensive genetic testing services. We have carefully examined the biotechnological horizon to identify the genetic tests most relevant to this region and offer them directly to the people of the Middle East. www.easternbiotech.com www.easternbiotech.ae www.foodintolerancetest.ae www.dnaancestry.ae www.geneticcounseling.ae www.telomeretest.ae Molecular Diagnostics, Paternity Testing, Rapid Diagnostics, Advance Healthcare Mangement, Biotechnology, and Wellness Test | 3 | 0 | 3 | 10 | |
Cancer Research UK Manchester Institute Cellular heterogeneity in cancer: from mechanism to clinic Cancer Research UK Manchester Institute is a leading cancer research institute within The University of Manchester, core funded by Cancer Research UK, the largest independent cancer research organisation in the world. Research spans the whole spectrum of cancer research, from programmes investigating the molecular and cellular basis of cancer, to those focussed on translational research and the development of therapeutics. Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 6 | 2 | 4 | 124 | |
Prize4Life Prize4Life is a results-oriented non-profit organization with the mission of finding innovative and ground-breaking treatments and cures for ALS (Amyotrophic Lateral Sclerosis, a.k.a Lou Gehrig's disease or MND). This is done in several ways: -- Inducement prize model – Prize4Life offers significant prizes for measurable achievements solving critical research problems and issues that are preventing the discovery of an effective ALS treatment. -- Expanding resources by attracting “new minds” from various disciplines, publicizing the fight against ALS, increasing awareness of this terrible disease and fundraising. -- investment in infrastructure for research -- Innovative assistive technology Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 2 | 2 | 1 | 1 | |
Kanteron Systems We took telemedicine to a whole new level. Invented the first Precision Medicine platform. And didn't survive Covid. Bye We took telemedicine to a whole new level. Invented the first Precision Medicine platform. And didn't survive the Covid-19 crisis. Thank you. We'll miss you. PACS, EHR, Medical Imaging, RIS, Digital Pathology, Genomics, Pharmacogenomics, BioSensors, and Precision Medicine Type: SMB Activities: healthtech biotech deeptech it services Technologies: SaaS | 1 | 0 | 1 | 3 | |
Catalent Pharma Solutions more products. better treatments. reliably supplied. TM Catalent Inc. (NYSE: CTLT), an S&P 500® company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent supports our partners in introducing 200 new products and manufacturing over 70 billion doses each year. Since becoming a publicly traded company in 2014, we have grown … Type: Large company Activities: biotech deeptech manufacturing | 30 | 8 | 11 | 13,892 | |
g.tec medical engineering GmbH - NEVER STOP RECORDING Brain-Computer Interfaces & Neurotechnology g.tec medical engineering was founded in 1999 as a spin-off from the Technical University in Graz, Austria. Christoph Guger and Günter Edlinger developed the first commercial Brain-Computer Interface (BCI) system at this time. As a producer of state-of-the-art invasive and non-invasive BCI systems with sales and research partners worldwide, g.tec is a leader in the fields of BCI, medical devices, neurotechnology, neurorehabilitation and biosignal processing with branches in Schiedlberg and Graz (Austria), Barcelona (Spain), and New York (USA). g.tec’s BCI systems are realized by four major principles: slow waves, steady-state visual evoked potentials (SSVEP), motor imagery … Type: SMB Activities: healthtech biotech deeptech manufacturing Technologies: Affective Computing Synthetic Biology | 4 | 2 | 2 | 73 | |
Nemaura Pharma Limited Unlock the potential of your drug with our expertise in Transdermal and complex Injectable product development Nemaura Pharma is a private specialist biotech company who have developed several advanced versatile skin drug delivery systems. Our technologies have been designed with clinical needs in mind and are all minimally invasive and very cost-effective. We are strategically positioned to work with global pharmaceutical companies, as well as new biotechnology companies, to successfully bring both new and old drugs to patients in superior delivery formulations and systems. Founded in 2005 Nemaura has its headquarters and laboratory facilities in the United Kingdom at the … Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 36 | |
Celyad Oncology Developing Innovative Cell Therapies Against Cancer Celyad Oncology is a biotechnology company focused on the discovery and development of tecnhlologies and platform for chimeric antigen receptor T cell (CAR T) therapies. Celyad Oncology was founded in 2007 and is based in Mont-Saint-Guibert, Belgium and New York, NY. The Company has received funding from the Walloon Region (Belgium) to support the advancement of its CAR T cell therapy programs. For more information, please visit www.celyad.com. Immuno-Oncology, Cancer, Immnotherapy, shRNA multiplex, and CAR T-cells Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 44 | |
Radiotherapy UK Standing up for vital cancer treatment Radiotherapy UK is the only charity dedicated to improving radiotherapy treatment throughout the UK. We believe that everyone in the country – no matter who they are or where they live – should have access to the best radiotherapy treatment available. We are committed to supporting and promoting radiotherapy professionals across the NHS and private sector. We work with industry partners, professional bodies and cancer charities to raise the profile of radiotherapy and its highly specialised workforce. Radiotherapy, Radiation Therapy, Cancer, Radiotherapy Jobs, Daily Radiotherapy News, Technical Radiotherapy Forum, Radiotherapy Service Documents, and Cancer … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech | 5 | 0 | 5 | 19 | |
Lobular Breast Cancer Alliance Inc. LBCA's vision is a world in which lobular breast cancer is found early, treated effectively, and eradicated permanently. As the only organization in the US dedicated to Invasive Lobular Breast Cancer (ILC), LBCA’s mission is to make all who are touched by ILC aware of its unique characteristics and the critical need for more ILC research, to be the go-to source for information on ILC studies, clinical trials and educational tools, to foster relationships among patients, scientists and clinicians to increase dialogue about ILC and patient advocacy, and to fund vital ILC research. lobular breast cancer, invasive lobular carcinoma, ILC, … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 3 | 0 | 3 | 13 | |
P-CMR[C] Program for Clinical Translation of Regenerative Medicine in Catalonia Advancing the clinical translation of regenerative medicine. The Program for advancing the Clinical Translation of Regenerative Medicine of Catalonia, P-CMR[C], has been launched by the Center for Regenerative Medicine (CMR[B]) and the Biomedical Research Institute of Bellvitge (IDIBELL), at the behest of the Catalan Health Department of the Generalitat de Catalonia. P-CMR[C] was born with the aim to have a transformative impact on the way that basic, pre-clinical and clinical research in regenerative medicine are currently coordinated and eventually transferred to clinical practice in Catalonia. We are a comprehensive program where basic research, pre-clinical studies with new therapies and clinical … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech | 1 | 0 | 1 | 40 | |
Pancreatic Cancer UK Together we’ll transform the future of pancreatic cancer. https://www.pancreaticcancer.org.uk/ We bring more breakthroughs through research, more change through campaigning, and more support through our expert nurses. Because people with pancreatic cancer need more than hope. Pancreatic Cancer Support, Pancreatic Cancer Research Funding, Awareness Raising, and Political Campaigning Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech | 3 | 1 | 1 | 137 | |
BIO Deutschland e. V. Healing, Feeding, Fueling - Biotechnology BIO Deutschland is the sector association of the biotechnology industry and has set itself the goal of supporting the development of an innovative branch of industry based on modern life sciences. The association has around 350 member companies and organizations and numerous national and international partners. Cheese, wine, beer and bread, but also cancer drugs, pregnancy tests, detergents and jeans: all these products are created with the help of biotechnology. Further information can be found in our so-called Biothek here: https://www.biodeutschland.org/de/biothek.html Unternehmertum, Wachstumsfinanzierung, Healthcare, Life Sciences, Bioökonomie, Diagnostik, Nachhaltigkeit, Technologietransfer, Industrielle Zelltechnik, Biotechnologie, Spitzentechnologie, Forschungs- … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech | 30 | 3 | 25 | 15 | |
CompBioMed CompBioMed, a Centre of Excellence on the use and development of computational methods for biomedical applications. CompBioMed is a European Commission H2020 funded Centre of Excellence focused on the use and development of computational methods for biomedical applications. We have users within academia, industry and clinical environments and are working to train more people in the use of our products and methods. Our website features user pages for each of these areas, which will give you more information on the work we are doing, relevant to your field, and our services which may provide further information on our work and … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 10 | 2 | 7 | 6 | |
American Society for Cell Biology (ASCB) an international forum for cell biology Over 5,000 members, 40 nobel laureates, and YOU! The American Society for Cell Biology (ASCB) is an inclusive, international community of scientists in cell biology and biomedical research. We are dedicated to advancing scientific discovery, advocating sound research policies, improving education, promoting professional development, and increasing diversity in the scientific workforce. Our membership ranges from undergraduate students to thought leaders in cell biology and basic science with benefits designed for each stage of your career. Where science happens and the future of cell biology begins cell biology, biomedical research, genetics, neuroscience, biophysics, epidemiology, basic … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 2 | 1 | 0 | 65 | |
Advancells Stem Cell Research & Development in India. Advancells offers stem cells for various chronic conditions and lifestyle disorders. Stem Cell Processing Laboratory , stem cells, and stem cells provider Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech | 4 | 0 | 4 | 24 | |
ICGEB Research, training, technology transfer to industry; Biotechnology excellence to promote sustainable global development The International Centre for Genetic Engineering and Biotechnology ICGEB is an intergovernmental research organisation that operates within the United Nations common system. It was established in 1983 as a Centre for excellence in research, training and technology transfer to industry in the field of biotechnology to promote sustainable global development. With over 60 Member States and 40 Affiliated Centres worldwide, it runs 46 research programmes in its own laboratories in Trieste, Italy, New Delhi, India and Cape Town, South Africa. Almost 700 people work at ICGEB comprising … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 20 | 1 | 8 | 465 | |
Fundación Vencer el Cáncer [Automatic translation follows] Our goal: to finance cancer research to develop new drugs and early detection methods. Vencer el Cáncer (VEC) is a Foundation whose challenge is to raise awareness and convince Spaniards that their contribution is needed to finance cancer research: new, safer and more effective drugs are needed, but many years of research and large investments are needed to develop them. Public funds are not sufficient to make these treatments available quickly, which is why it is necessary to obtain private funds. VEC obtains its resources from private and individual donations and the collaboration of companies, with which … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 5 | 0 | 5 | 3 |